PHIO PHARMACEUTICALS CORP. Amortization of Leased Asset
PHIO PHARMACEUTICALS CORP. (PHIO) reported Amortization of Leased Asset of $9.00 thousand for the 12-month period ending 2013-12-31, per its 10-K filed 2014-03-28.
Discontinued › Expense Statement › Operating Expenses
us-gaap:AmortizationOfLeasedAsset · last filed 2014-03-28
- PHIO PHARMACEUTICALS CORP. amortization of leased asset for fiscal 2013 was $9.00K, a 52.63% decline from fiscal 2012.
- PHIO PHARMACEUTICALS CORP. amortization of leased asset for fiscal 2012 was $19.00K, a 64.15% decline from fiscal 2011.
- PHIO PHARMACEUTICALS CORP. amortization of leased asset for fiscal 2011 was $53.00K.
| Period end | Amortization of Leased Asset 12 month |
|---|---|
| 2013-12-31 | $9.00K 10-K · filed 2014-03-28 |
| 2012-12-31 | $19.00K 10-K · filed 2014-03-28 |
| 2011-12-31 | $53.00K 10-K · filed 2013-03-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ADIAL PHARMACEUTICALS, INC. (ADIL) | United States | $0.012B | |
| Scienture Holdings, Inc. (SCNX) | United States | $0.012B | -0.38 |
| KIORA PHARMACEUTICALS INC (KPRX) | United States | $0.012B | |
| BIOVIE INC. (BIVI) | United States | $0.012B | |
| Dare Bioscience, Inc. (DARE) | United States | $0.011B | |
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |
| Tempest Therapeutics, Inc. (TPST) | United States | $0.013B | |
| Moleculin Biotech, Inc. (MBRX) | United States | $0.011B | |
| MetaVia Inc. (MTVA) | United States | $0.011B | -0.65 |
| KALA BIO, Inc. (KALA) | United States | $0.011B | -3.33 |